We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
-5.25%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$578B
AUM Growth
-$88.6B
Cap. Flow
+$4.3B
Cap. Flow %
0.74%
Top 10 Hldgs %
34.17%
Holding
14,706
New
1,657
Increased
4,873
Reduced
6,001
Closed
1,835

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.98B
2
META icon
Meta Platforms (Facebook)
META
+$997M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$860M
4
WDAY icon
Workday
WDAY
+$691M
5
AMZN icon
Amazon
AMZN
+$616M

Top Sells

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$498M
2
GDX icon
VanEck Gold Miners ETF
GDX
+$420M
3
FDX icon
FedEx
FDX
+$350M
4
VALE icon
Vale
VALE
+$340M
5
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$322M

Sector Composition

Rank Sector Weight
1 Miscellaneous 91.96%
2 Technology 2.07%
3 Consumer Discretionary 1.49%
4 Financials 1.12%
5 Communication Services 1.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OPFI icon
12176
PUT
OppFi
OPFI
$602M
$56K ﹤0.01%
16,300
-13,200
-45% -$55.9K
TRUE
12177
CALL
DELISTED
TrueCar
TRUE
$56K ﹤0.01%
+14,300
New +$50.5K
TXMD icon
12178
PUT
TherapeuticsMD
TXMD
$25.7M
$56K ﹤0.01%
2,924
-1,898
-39% -$29.9K
VMD icon
12179
Viemed Healthcare
VMD
$336M
$56K ﹤0.01%
+11,166
New +$51.8K
CRHC.WS
12180
DELISTED
Cohn Robbins Holdings Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
CRHC.WS
$56K ﹤0.01%
72,188
+15,522
+27% +$11K
ZY
12181
CALL
DELISTED
Zymergen Inc. Common Stock
ZY
$56K ﹤0.01%
19,300
-57,500
-75% -$244K
ACIC icon
12182
American Coastal Insurance
ACIC
$449M
$55K ﹤0.01%
16,495
-61,063
-79% -$231K
CCLD icon
12183
CareCloud
CCLD
$106M
$55K ﹤0.01%
10,652
-1,196
-10% -$6.55K
CLIR icon
12184
PUT
ClearSign Technologies
CLIR
$30.4M
$55K ﹤0.01%
3,400
-1,870
-35% -$24.3K
HYPD
12185
Hyperion DeFi Inc
HYPD
$50.7M
$55K ﹤0.01%
224
-423
-65% -$105K
SURF
12186
PUT
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$55K ﹤0.01%
18,800
-37,900
-67% -$133K
BCDA icon
12187
CALL
BioCardia
BCDA
$17.4M
$54K ﹤0.01%
+1,740
New +$51.7K
CBIO
12188
Crescent Biopharma
CBIO
$659M
$54K ﹤0.01%
476
-2,176
-82% -$255K
GTBP icon
12189
GT Biopharma
GTBP
$13.5M
$54K ﹤0.01%
628
-1,231
-66% -$109K
RNXT icon
12190
RenovoRx
RNXT
$75.4M
$54K ﹤0.01%
+18,582
New +$65.1K
VEV
12191
DELISTED
Vicinity Motor Corp. Common Stock
VEV
$54K ﹤0.01%
+22,393
New +$75.1K
AFIB
12192
DELISTED
Acutus Medical Inc
AFIB
$54K ﹤0.01%
38,737
-422
-1% -$902
AMPE
12193
PUT
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$54K ﹤0.01%
381
-32
-8% -$4.67K
CRTD
12194
DELISTED
Creatd Inc. Common Stock
CRTD
$54K ﹤0.01%
46,805
-34,435
-42% -$54.1K
BKYI
12195
CALL
BIO-key International
BKYI
$4.42M
$53K ﹤0.01%
122
-53
-30% -$21.4K
BRW
12196
Saba Capital Income & Opportunities Fund
BRW
$332M
$53K ﹤0.01%
5,881
– –
IGC icon
12197
PUT
IGC Pharma
IGC
$32M
$53K ﹤0.01%
55,400
-56,300
-50% -$54.7K
IRIX icon
12198
IRIDEX
IRIX
$12.3M
$53K ﹤0.01%
11,358
+922
+9% +$4.56K
MLSS icon
12199
PUT
Milestone Scientific
MLSS
$44.5M
$53K ﹤0.01%
34,600
+22,300
+181% +$32.5K
OWLT icon
12200
PUT
Owlet
OWLT
$146M
$53K ﹤0.01%
850
-10,036
-92% -$346K
486 487
488
489 490

Similar funds

Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Jeff Yass's Q1 2022 Portfolio in Review

As of Q1 2022, Jeff Yass held 14,706 positions worth $578B, down 13% from $667B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Jeff Yass's Q1 2022 filing shows 1,657 new, 4,873 increased, 6,001 reduced and 1,835 closed positions. Its largest new stake was iShares JPMorgan USD Emerging Markets Bond ETF: 1,089,723 shares worth $107M. The largest sale was Walt Disney, an estimated $498M.

By sector, the portfolio is most concentrated in Miscellaneous at 92% of assets, down from 93% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Jeff Yass's largest Q1 2022 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 1,089,723 shares worth $107M.
  • Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $1.98B increase.
  • Jeff Yass's biggest Q1 2022 reduction was Walt Disney, cutting an estimated $498M.
  • Jeff Yass fully exited Xilinx Inc in Q1 2022, selling an estimated $217M.
  • Jeff Yass's ten largest holdings make up 34% of its $578B portfolio in Q1 2022.
  • Jeff Yass opened 1,657 new positions and closed 1,835 in Q1 2022.
  • Jeff Yass's portfolio value fell 13% quarter-over-quarter to $578B.

Based on Susquehanna International Group's 13F filing for Q1 2022, filed 16 May 2022.